Get the Stockscreener App
6.5872
0.46%
0.0372
Bioventus Inc stock is traded at $6.5872, with a volume of 192.09K.
It is up +0.46% in the last 24 hours and down -6.27% over the past month.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
See More
Previous Close:
$6.55
Open:
$6.52
24h Volume:
192.09K
Relative Volume:
0.55
Market Cap:
$441.49M
Revenue:
$555.06M
Net Income/Loss:
$-39.48M
P/E Ratio:
-10.98
EPS:
-0.6
Net Cash Flow:
$29.05M
1W Performance:
-1.94%
1M Performance:
-6.27%
6M Performance:
-10.35%
1Y Performance:
-51.55%
1-Day Range:
$6.50
$6.75
1-Week Range:
$6.50
$7.15
52-Week Range:
$5.81
$14.38
Bioventus Inc Stock (BVS) Company Profile
Name
Bioventus Inc
Sector
Industry
Phone
(919) 474-6700
Address
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Compare BVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
6.60 | 438.14M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
123.73 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.78 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
359.12 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.96 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.14 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-17-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Dec-07-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-09-23 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-22-22 | Downgrade | Craig Hallum | Buy → Hold |
| Nov-09-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-09-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Mar-15-22 | Initiated | Craig Hallum | Buy |
| Nov-15-21 | Resumed | Morgan Stanley | Overweight |
| Nov-10-21 | Resumed | JP Morgan | Overweight |
| Jul-01-21 | Downgrade | Goldman | Buy → Neutral |
| Mar-08-21 | Initiated | Canaccord Genuity | Buy |
| Mar-08-21 | Initiated | Goldman | Buy |
| Mar-08-21 | Initiated | JP Morgan | Overweight |
| Mar-08-21 | Initiated | Morgan Stanley | Overweight |
View All
Bioventus Inc Stock (BVS) Latest News
Is Bioventus Inc. stock attractive for income investors2025 Retail Activity & Free Real-Time Market Sentiment Alerts - newser.com
How strong is Bioventus Inc. stock revenue growth2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com
What To Expect From Bioventus Inc (BVS) Q3 2025 Earnings - Yahoo Finance
Developing predictive dashboards with Bioventus Inc. dataPortfolio Value Report & Accurate Buy Signal Notifications - newser.com
What the charts say about Bioventus Inc. today2025 Earnings Impact & Momentum Based Trading Ideas - newser.com
Can Bioventus Inc. rally from current levelsLayoff News & Free Community Supported Trade Ideas - newser.com
Bioventus Inc. stock prediction for this weekLong Setup & Accurate Entry/Exit Alerts - newser.com
Should you wait for a breakout in Bioventus Inc.Earnings Risk Report & Step-by-Step Trade Execution Guides - newser.com
Will Bioventus Inc. stock deliver long term returnsMarket Growth Report & Reliable Price Breakout Alerts - newser.com
Will Bioventus Inc. stock maintain momentum in 2025July 2025 Intraday Action & AI Forecasted Entry and Exit Points - newser.com
Can Bioventus Inc. stock sustain free cash flow growth2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Short interest data insights for Bioventus Inc.July 2025 PostEarnings & Weekly Top Gainers Trade List - newser.com
Why Bioventus Inc. stock is trending among retail tradersBond Market & Capital Efficiency Focused Ideas - newser.com
Detecting price anomalies in Bioventus Inc. with AIInflation Watch & Technical Pattern Alert System - newser.com
Backtesting results for Bioventus Inc. trading strategiesEarnings Recap Summary & Safe Investment Capital Preservation Plans - newser.com
Is Bioventus Inc. stock recession proofQuarterly Profit Report & AI Powered Market Entry Ideas - newser.com
Bioventus Inc. stock chart pattern explained2025 Breakouts & Breakdowns & Intraday High Probability Alerts - newser.com
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025 - The Manila Times
Bioventus (NASDAQ: BVS) to report Q3 FY2025 before open; 8:30 a.m. ET call - Stock Titan
Bioventus Inc Stock (BVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.21%
1.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):